Analyze Diet
Cells2023; 12(7); 1052; doi: 10.3390/cells12071052

Spontaneous Sepsis in Adult Horses: From Veterinary to Human Medicine Perspectives.

Abstract: Sepsis is a life-threatening disease defined as an organ dysfunction caused by a dysregulated host response to an infection. Early diagnosis and prognosis of sepsis are necessary for specific and timely treatment. However, no predictive biomarkers or therapeutic targets are available yet, mainly due to the lack of a pertinent model. A better understanding of the pathophysiological mechanisms associated with sepsis will allow for earlier and more appropriate management. For this purpose, experimental models of sepsis have been set up to decipher the progression and pathophysiology of human sepsis but also to identify new biomarkers or therapeutic targets. These experimental models, although imperfect, have mostly been performed on a murine model. However, due to the different pathophysiology of the species, the results obtained in these studies are difficult to transpose to humans. This underlines the importance of identifying pertinent situations to improve patient care. As humans, horses have the predisposition to develop sepsis spontaneously and may be a promising model for spontaneous sepsis. This review proposes to give first an overview of the different animal species used to model human sepsis, and, secondly, to focus on adult equine sepsis as a spontaneous model of sepsis and its potential implications for human and veterinary medicine.
Publication Date: 2023-03-30 PubMed ID: 37048125PubMed Central: PMC10093263DOI: 10.3390/cells12071052Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the use of adult horses as a model for studying sepsis, a severe life-threatening condition resulting from an infection, in order to develop better diagnosis methods and potential treatments.

Summary of Research Objectives

  • The research aimed to find a reliable model for studying the progression of sepsis and its pathophysiology in humans.
  • The study further aimed to probe into the potential of adult horses as a unique spontaneous model for sepsis.
  • The research aimed at improving the early diagnosis and treatment approaches for sepsis through a deep understanding of its pathophysiology.

The Necessity for a Reliable Model

  • The authors point out that current models, mostly murine, are imperfect and have difficulty providing results applicable to humans due to significant physiological differences.
  • The article emphasizes the need for a model closely mimicking humans to enhance the understanding of sepsis progession and pathophysiology, thereby improving patient care.

Adult Horses as a Spontaneous Model

  • The paper highlights adult horses as potential models for the research of sepsis. Like humans, horses have a predisposition to develop sepsis spontaneously, making them a promising model to study disease processes.
  • The authors suggest that findings from adult equine sepsis could have significant implications for both human and veterinary medicine.

Scope and Limitations

  • The review explores the use of different animal species in modelling human sepsis, focusing specifically on adult horses.
  • While horses may offer a promising model for sepsis study, it’s necessary to approach this with a keen understanding of potential differences in sepsis physiology between horses and humans.

Cite This Article

APA
Blangy-Letheule A, Vergnaud A, Dupas T, Rozec B, Lauzier B, Leroux AA. (2023). Spontaneous Sepsis in Adult Horses: From Veterinary to Human Medicine Perspectives. Cells, 12(7), 1052. https://doi.org/10.3390/cells12071052

Publication

ISSN: 2073-4409
NlmUniqueID: 101600052
Country: Switzerland
Language: English
Volume: 12
Issue: 7
PII: 1052

Researcher Affiliations

Blangy-Letheule, Angélique
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Vergnaud, Amandine
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Dupas, Thomas
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Rozec, Bertrand
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
Lauzier, Benjamin
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
  • CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
Leroux, Aurélia A
  • Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.
  • Department of Clinical Sciences, Equine Veterinary Teaching Hospital (CISCO), Oniris, F-44300 Nantes, France.

MeSH Terms

  • Humans
  • Animals
  • Horses
  • Adult
  • Mice
  • Sepsis / veterinary
  • Sepsis / complications
  • Biomarkers
  • Early Diagnosis

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 103 references
  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).. JAMA 2016 Feb 23;315(8):801-10.
    doi: 10.1001/jama.2016.0287pmc: PMC4968574pubmed: 26903338google scholar: lookup
  2. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.. Lancet 2020 Jan 18;395(10219):200-211.
  3. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.. Am J Respir Crit Care Med 2016 Feb 1;193(3):259-72.
    doi: 10.1164/rccm.201504-0781OCpubmed: 26414292google scholar: lookup
  4. Kumar S, Tripathy S, Jyoti A, Singh SG. Recent advances in biosensors for diagnosis and detection of sepsis: A comprehensive review.. Biosens Bioelectron 2019 Jan 15;124-125:205-215.
    doi: 10.1016/j.bios.2018.10.034pubmed: 30388563google scholar: lookup
  5. Quenot JP, Pavon A, Fournel I, Barbar SD, Bruyère R. Le choc septique de l’adulte en France: Vingt ans de données épidémiologiques. Réanimation 2015;24:303–309.
    doi: 10.1007/s13546-015-1062-6google scholar: lookup
  6. Monneret G, Gossez M, Aghaeepour N, Gaudilliere B, Venet F. How Clinical Flow Cytometry Rebooted Sepsis Immunology.. Cytometry A 2019 Apr;95(4):431-441.
    doi: 10.1002/cyto.a.23749pmc: PMC6461502pubmed: 30887636google scholar: lookup
  7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.. Chest 1992 Jun;101(6):1644-55.
    doi: 10.1378/chest.101.6.1644pubmed: 1303622google scholar: lookup
  8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.. Intensive Care Med 2003 Apr;29(4):530-8.
    doi: 10.1007/s00134-003-1662-xpubmed: 12664219google scholar: lookup
  9. Teggert A, Datta H, Ali Z. Biomarkers for Point-of-Care Diagnosis of Sepsis.. Micromachines (Basel) 2020 Mar 10;11(3).
    doi: 10.3390/mi11030286pmc: PMC7143187pubmed: 32164268google scholar: lookup
  10. Murando F, Peloso A, Cobianchi L. Experimental Abdominal Sepsis: Sticking to an Awkward but Still Useful Translational Model.. Mediators Inflamm 2019;2019:8971036.
    doi: 10.1155/2019/8971036pmc: PMC6915118pubmed: 31885502google scholar: lookup
  11. Blangy-Letheule A, Persello A, Rozec B, Waard M, Lauzier B. New Approaches to Identify Sepsis Biomarkers: The Importance of Model and Sample Source for Mass Spectrometry.. Oxid Med Cell Longev 2020;2020:6681073.
    doi: 10.1155/2020/6681073pmc: PMC7775177pubmed: 33425215google scholar: lookup
  12. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG. Genomic responses in mouse models poorly mimic human inflammatory diseases.. Proc Natl Acad Sci U S A 2013 Feb 26;110(9):3507-12.
    doi: 10.1073/pnas.1222878110pmc: PMC3587220pubmed: 23401516google scholar: lookup
  13. . For sepsis, the drugs don't work.. Lancet Infect Dis 2012 Feb;12(2):89.
    doi: 10.1016/S1473-3099(12)70020-8pubmed: 22281132google scholar: lookup
  14. Guillon A, Preau S, Aboab J, Azabou E, Jung B, Silva S, Textoris J, Uhel F, Vodovar D, Zafrani L, de Prost N, Radermacher P. Preclinical septic shock research: why we need an animal ICU.. Ann Intensive Care 2019 Jun 10;9(1):66.
    doi: 10.1186/s13613-019-0543-6pmc: PMC6557957pubmed: 31183570google scholar: lookup
  15. Mai S, Khan M, Liaw P, Fox-Robichaud A. Experimental Sepsis Models. IntechOpen; London, UK: 2012.
  16. Nagy S, Tárnoky K, Tutsek L, Boros M, Karácsony G. A canine model of hyperdynamic sepsis induced by intestinal ischemia.. Acta Physiol Hung 1990;75(4):303-20.
    pubmed: 2075825
  17. Song R, Kim J, Yu D, Park C, Park J. Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin.. Vet Immunol Immunopathol 2012 Apr 15;146(2):143-9.
    doi: 10.1016/j.vetimm.2012.02.008pubmed: 22424937google scholar: lookup
  18. Fink MP, Heard SO. Laboratory models of sepsis and septic shock.. J Surg Res 1990 Aug;49(2):186-96.
    doi: 10.1016/0022-4804(90)90260-9pubmed: 2199735google scholar: lookup
  19. Michie HR. The value of animal models in the development of new drugs for the treatment of the sepsis syndrome.. J Antimicrob Chemother 1998 Jan;41 Suppl A:47-9.
    doi: 10.1093/jac/41.suppl_1.47pubmed: 9511086google scholar: lookup
  20. Ceciliani F, Restelli L, Lecchi C. Proteomics in farm animals models of human diseases.. Proteomics Clin Appl 2014 Oct;8(9-10):677-88.
    doi: 10.1002/prca.201300080pubmed: 24595991google scholar: lookup
  21. Groenen MA, Archibald AL, Uenishi H, Tuggle CK, Takeuchi Y, Rothschild MF, Rogel-Gaillard C, Park C, Milan D, Megens HJ, Li S, Larkin DM, Kim H, Frantz LA, Caccamo M, Ahn H, Aken BL, Anselmo A, Anthon C, Auvil L, Badaoui B, Beattie CW, Bendixen C, Berman D, Blecha F, Blomberg J, Bolund L, Bosse M, Botti S, Bujie Z, Bystrom M, Capitanu B, Carvalho-Silva D, Chardon P, Chen C, Cheng R, Choi SH, Chow W, Clark RC, Clee C, Crooijmans RP, Dawson HD, Dehais P, De Sapio F, Dibbits B, Drou N, Du ZQ, Eversole K, Fadista J, Fairley S, Faraut T, Faulkner GJ, Fowler KE, Fredholm M, Fritz E, Gilbert JG, Giuffra E, Gorodkin J, Griffin DK, Harrow JL, Hayward A, Howe K, Hu ZL, Humphray SJ, Hunt T, Hornshøj H, Jeon JT, Jern P, Jones M, Jurka J, Kanamori H, Kapetanovic R, Kim J, Kim JH, Kim KW, Kim TH, Larson G, Lee K, Lee KT, Leggett R, Lewin HA, Li Y, Liu W, Loveland JE, Lu Y, Lunney JK, Ma J, Madsen O, Mann K, Matthews L, McLaren S, Morozumi T, Murtaugh MP, Narayan J, Nguyen DT, Ni P, Oh SJ, Onteru S, Panitz F, Park EW, Park HS, Pascal G, Paudel Y, Perez-Enciso M, Ramirez-Gonzalez R, Reecy JM, Rodriguez-Zas S, Rohrer GA, Rund L, Sang Y, Schachtschneider K, Schraiber JG, Schwartz J, Scobie L, Scott C, Searle S, Servin B, Southey BR, Sperber G, Stadler P, Sweedler JV, Tafer H, Thomsen B, Wali R, Wang J, Wang J, White S, Xu X, Yerle M, Zhang G, Zhang J, Zhang J, Zhao S, Rogers J, Churcher C, Schook LB. Analyses of pig genomes provide insight into porcine demography and evolution.. Nature 2012 Nov 15;491(7424):393-8.
    doi: 10.1038/nature11622pmc: PMC3566564pubmed: 23151582google scholar: lookup
  22. Mair KH, Sedlak C, Käser T, Pasternak A, Levast B, Gerner W, Saalmüller A, Summerfield A, Gerdts V, Wilson HL, Meurens F. The porcine innate immune system: an update.. Dev Comp Immunol 2014 Aug;45(2):321-43.
    doi: 10.1016/j.dci.2014.03.022pmc: PMC7103209pubmed: 24709051google scholar: lookup
  23. Bassols A, Costa C, Eckersall PD, Osada J, Sabrià J, Tibau J. The pig as an animal model for human pathologies: A proteomics perspective.. Proteomics Clin Appl 2014 Oct;8(9-10):715-31.
    doi: 10.1002/prca.201300099pubmed: 25092613google scholar: lookup
  24. Bendixen E. Animal models for translational proteomics.. Proteomics Clin Appl 2014 Oct;8(9-10):637-9.
    doi: 10.1002/prca.201470054pubmed: 25274148google scholar: lookup
  25. Cohen RI, Hassell AM, Marzouk K, Marini C, Liu SF, Scharf SM. Renal effects of nitric oxide in endotoxemia.. Am J Respir Crit Care Med 2001 Nov 15;164(10 Pt 1):1890-5.
    doi: 10.1164/ajrccm.164.10.2103140pubmed: 11734442google scholar: lookup
  26. Ji MH, Yang JJ, Wu J, Li RQ, Li GM, Fan YX, Li WY. Experimental sepsis in pigs--effects of vasopressin on renal, hepatic, and intestinal dysfunction.. Ups J Med Sci 2012 Aug;117(3):257-63.
  27. Maybauer DM, Maybauer MO, Szabó C, Cox RA, Westphal M, Kiss L, Horvath EM, Traber LD, Hawkins HK, Salzman AL, Southan GJ, Herndon DN, Traber DL. The peroxynitrite catalyst WW-85 improves pulmonary function in ovine septic shock.. Shock 2011 Feb;35(2):148-55.
  28. Traber DL, Redl H, Schlag G, Herndon DN, Kimura R, Prien T, Traber LD. Cardiopulmonary responses to continuous administration of endotoxin.. Am J Physiol 1988 May;254(5 Pt 2):H833-9.
  29. Taylor S. A review of equine sepsis.. Equine Vet Educ 2015 Feb;27(2):99-109.
    doi: 10.1111/eve.12290pmc: PMC7163761pubmed: 32313390google scholar: lookup
  30. McGovern KF, Lascola KM, Smith SA, Clark-Price SC, Wilkins PA, Schaeffer DJ, Foreman JH. The effects of hyperglycemia and endotoxemia on coagulation parameters in healthy adult horses.. J Vet Intern Med 2013 Mar-Apr;27(2):347-53.
    doi: 10.1111/jvim.12052pubmed: 23480666google scholar: lookup
  31. Holcombe SJ, Jacobs CC, Cook VL, Gandy JC, Hauptman JG, Sordillo LM. Duration of in vivo endotoxin tolerance in horses.. Vet Immunol Immunopathol 2016 May;173:10-6.
    doi: 10.1016/j.vetimm.2016.03.016pubmed: 27090620google scholar: lookup
  32. Scavone D, Sgorbini M, Borges AS, Oliveira-Filho JP, Vitale V, Paltrinieri S. Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia.. BMC Vet Res 2020 Nov 4;16(1):422.
    doi: 10.1186/s12917-020-02629-4pmc: PMC7641807pubmed: 33148245google scholar: lookup
  33. Castellano G, Stasi A, Intini A, Gigante M, Di Palma AM, Divella C, Netti GS, Prattichizzo C, Pontrelli P, Crovace A, Staffieri F, Fiaccadori E, Brienza N, Grandaliano G, Pertosa G, Gesualdo L. Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein.. Crit Care 2014 Sep 27;18(5):520.
    doi: 10.1186/s13054-014-0520-2pmc: PMC4205288pubmed: 25261195google scholar: lookup
  34. Anderson JR, Smagul A, Simpson D, Clegg PD, Rubio-Martinez LM, Peffers MJ. The synovial fluid proteome differentiates between septic and nonseptic articular pathologies.. J Proteomics 2019 Jun 30;202:103370.
    doi: 10.1016/j.jprot.2019.04.020pmc: PMC6549134pubmed: 31028944google scholar: lookup
  35. Borde L, Amory H, Grulke S, Leroux AA, Houben RM, Detilleux J, Sandersen CC. Prognostic value of echocardiographic and Doppler parameters in horses admitted for colic complicated by systemic inflammatory response syndrome.. J Vet Emerg Crit Care (San Antonio) 2014 May-Jun;24(3):302-10.
    doi: 10.1111/vec.12177pubmed: 24690095google scholar: lookup
  36. McConachie E, Giguère S, Barton MH. Scoring System for Multiple Organ Dysfunction in Adult Horses with Acute Surgical Gastrointestinal Disease.. J Vet Intern Med 2016 Jul;30(4):1276-83.
    doi: 10.1111/jvim.14321pmc: PMC5094519pubmed: 27296454google scholar: lookup
  37. Satué K, Gardon JC, Muñoz A. Clinical and laboratorial description of the differential diagnoses of hemostatic disorders in the horse.. Iran J Vet Res 2020 Winter;21(1):1-8.
    pmc: PMC7183377pubmed: 32368218
  38. Senior JM, Proudman CJ, Leuwer M, Carter SD. Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes.. Equine Vet J 2011 Sep;43(5):585-91.
  39. Osterbur K, Mann FA, Kuroki K, DeClue A. Multiple organ dysfunction syndrome in humans and animals.. J Vet Intern Med 2014 Jul-Aug;28(4):1141-51.
    doi: 10.1111/jvim.12364pmc: PMC4857933pubmed: 24773159google scholar: lookup
  40. Roy MF, Kwong GP, Lambert J, Massie S, Lockhart S. Prognostic Value and Development of a Scoring System in Horses With Systemic Inflammatory Response Syndrome.. J Vet Intern Med 2017 Mar;31(2):582-592.
    doi: 10.1111/jvim.14670pmc: PMC5354005pubmed: 28207163google scholar: lookup
  41. Moore JN, Vandenplas ML. Is it the systemic inflammatory response syndrome or endotoxemia in horses with colic?. Vet Clin North Am Equine Pract 2014 Aug;30(2):337-51, vii-viii.
    doi: 10.1016/j.cveq.2014.04.003pubmed: 25016495google scholar: lookup
  42. Schwarz BC, van den Hoven R, Schwendenwein I. Diagnostic value of the neutrophil myeloperoxidase index in horses with systemic inflammation.. Vet J 2012 Jan;191(1):72-8.
    doi: 10.1016/j.tvjl.2010.12.010pubmed: 21262582google scholar: lookup
  43. Aguirre CN, Talavera J, Fernández Del Palacio MJ. Usefulness of Doppler ultrasonography to assess digital vascular dynamics in horses with systemic inflammatory response syndrome or laminitis.. J Am Vet Med Assoc 2013 Dec 15;243(12):1756-61.
    doi: 10.2460/javma.243.12.1756pubmed: 24299548google scholar: lookup
  44. Epstein KL, Brainard BM, Giguere S, Vrono Z, Moore JN. Serial viscoelastic and traditional coagulation testing in horses with gastrointestinal disease.. J Vet Emerg Crit Care (San Antonio) 2013 Sep-Oct;23(5):504-16.
    doi: 10.1111/vec.12095pubmed: 24028350google scholar: lookup
  45. Hoffman AM, Staempfli HR, Willan A. Prognostic variables for survival of neonatal foals under intensive care.. J Vet Intern Med 1992 Mar-Apr;6(2):89-95.
  46. Cohen ND, Parson EM, Seahorn TL, Carter GK. Prevalence and factors associated with development of laminitis in horses with duodenitis/proximal jejunitis: 33 cases (1985-1991).. J Am Vet Med Assoc 1994 Jan 15;204(2):250-4.
    pubmed: 8144386
  47. Werners AH, Bull S, Fink-Gremmels J. Endotoxaemia: a review with implications for the horse.. Equine Vet J 2005 Jul;37(4):371-83.
    doi: 10.2746/0425164054529418pubmed: 16028631google scholar: lookup
  48. Peek SF, Semrad S, McGuirk SM, Riseberg A, Slack JA, Marques F, Coombs D, Lien L, Keuler N, Darien BJ. Prognostic value of clinicopathologic variables obtained at admission and effect of antiendotoxin plasma on survival in septic and critically ill foals.. J Vet Intern Med 2006 May-Jun;20(3):569-74.
  49. Strimbu K, Tavel JA. What are biomarkers?. Curr Opin HIV AIDS 2010 Nov;5(6):463-6.
  50. Okabayashi K, Wada H, Ohta S, Shiku H, Nobori T, Maruyama K. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.. Am J Hematol 2004 Jul;76(3):225-9.
    doi: 10.1002/ajh.20089pubmed: 15224356google scholar: lookup
  51. Manocha S, Russell JA, Sutherland AM, Wattanathum A, Walley KR. Fibrinogen-beta gene haplotype is associated with mortality in sepsis.. J Infect 2007 Jun;54(6):572-7.
    doi: 10.1016/j.jinf.2006.10.001pubmed: 17116333google scholar: lookup
  52. Garcia-Obregon S, Azkargorta M, Seijas I, Pilar-Orive J, Borrego F, Elortza F, Boyano MD, Astigarraga I. Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients.. J Microbiol Immunol Infect 2018 Aug;51(4):465-472.
    doi: 10.1016/j.jmii.2016.12.002pubmed: 28655573google scholar: lookup
  53. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care.. J Antimicrob Chemother 2011 Apr;66 Suppl 2:ii33-40.
    doi: 10.1093/jac/dkq523pubmed: 21398306google scholar: lookup
  54. Allen BV, Kold SE. Fibrinogen response to surgical tissue trauma in the horse.. Equine Vet J 1988 Nov;20(6):441-3.
  55. Crisman MV, Scarratt WK, Zimmerman KL. Blood proteins and inflammation in the horse.. Vet Clin North Am Equine Pract 2008 Aug;24(2):285-97, vi.
    doi: 10.1016/j.cveq.2008.03.004pubmed: 18652956google scholar: lookup
  56. Levi M, van der Poll T. Coagulation and sepsis.. Thromb Res 2017 Jan;149:38-44.
  57. Prasse KW, Topper MJ, Moore JN, Welles EG. Analysis of hemostasis in horses with colic.. J Am Vet Med Assoc 1993 Sep 1;203(5):685-93.
    pubmed: 8407538
  58. Topper MJ, Prasse KW. Analysis of coagulation proteins as acute-phase reactants in horses with colic.. Am J Vet Res 1998 May;59(5):542-5.
    pubmed: 9582953
  59. Collatos C, Barton MH, Prasse KW, Moore JN. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.. J Am Vet Med Assoc 1995 Aug 15;207(4):465-70.
    pubmed: 7591947
  60. Borges AS, Divers TJ, Stokol T, Mohammed OH. Serum iron and plasma fibrinogen concentrations as indicators of systemic inflammatory diseases in horses.. J Vet Intern Med 2007 May-Jun;21(3):489-94.
  61. Jacobsen S. Review of Equine Acute-Phase Proteins. Infect. Dis. 2007;53:230–235.
  62. Jacobsen S, Andersen PH. The Acute Phase Protein Serum Amyloid A (SAA) as a Marker of Inflammation in Horses. Equine Vet. Educ. 2010;19:38–46.
  63. Andrews DA, Reagan WJ, DeNicola DB. Plasma Fibrinogen in Recognizing Equine Inflammatory Disease. Compend. Contin. Educ. Pract. Vet. USA 1994;16:1354–1366.
  64. Prinsen BH, Rabelink TJ, Beutler JJ, Kaysen GA, De Boer J, Boer WH, Hagen EC, Berger R, De Sain-Van Der Velden MG. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure.. Kidney Int 2003 Oct;64(4):1495-504.
  65. Fiusa MM, Carvalho-Filho MA, Annichino-Bizzacchi JM, De Paula EV. Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective.. BMC Med 2015 May 6;13:105.
    doi: 10.1186/s12916-015-0327-2pmc: PMC4422540pubmed: 25943883google scholar: lookup
  66. Rodelo JR, De la Rosa G, Valencia ML, Ospina S, Arango CM, Gómez CI, García A, Nuñez E, Jaimes FA. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis.. Am J Emerg Med 2012 Nov;30(9):1991-9.
    doi: 10.1016/j.ajem.2012.04.033pubmed: 22795996google scholar: lookup
  67. Sandholm M, Vidovic A, Puotunen-Reinert A, Sankari S, Nyholm K, Rita H. D-dimer improves the prognostic value of combined clinical and laboratory data in equine gastrointestinal colic.. Acta Vet Scand 1995;36(2):255-72.
    doi: 10.1186/BF03547694pmc: PMC8095414pubmed: 7484552google scholar: lookup
  68. Monreal L, Anglés A, Espada Y, Monasterio J, Monreal M. Hypercoagulation and hypofibrinolysis in horses with colic and DIC.. Equine Vet J Suppl 2000 Jun;(32):19-25.
  69. Stokol T, Erb HN, De Wilde L, Tornquist SJ, Brooks M. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.. Vet Clin Pathol 2005 Dec;34(4):375-82.
  70. Delgado MA, Monreal L, Armengou L, Ríos J, Segura D. Peritoneal D-dimer concentration for assessing peritoneal fibrinolytic activity in horses with colic.. J Vet Intern Med 2009 Jul-Aug;23(4):882-9.
  71. Cesarini C, Monreal L, Armengou L, Delgado MÁ, Ríos J, Jose-Cunilleras E. Association of admission plasma D-dimer concentration with diagnosis and outcome in horses with colic.. J Vet Intern Med 2010 Nov-Dec;24(6):1490-7.
  72. Ye RD, Sun L. Emerging functions of serum amyloid A in inflammation.. J Leukoc Biol 2015 Dec;98(6):923-9.
    doi: 10.1189/jlb.3VMR0315-080Rpmc: PMC6608020pubmed: 26130702google scholar: lookup
  73. Wang S, Zhang X, Tan L. Serum Amyloid a Promotes Visfatin Expression in Macrophages.. Biomed Res Int 2016;2016:4819327.
    doi: 10.1155/2016/4819327pmc: PMC4783535pubmed: 27006946google scholar: lookup
  74. Vandenplas ML, Moore JN, Barton MH, Roussel AJ, Cohen ND. Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic.. Am J Vet Res 2005 Sep;66(9):1509-16.
    doi: 10.2460/ajvr.2005.66.1509pubmed: 16261823google scholar: lookup
  75. Jacobsen S, Nielsen JV, Kjelgaard-Hansen M, Toelboell T, Fjeldborg J, Halling-Thomsen M, Martinussen T, Thoefner MB. Acute phase response to surgery of varying intensity in horses: a preliminary study.. Vet Surg 2009 Aug;38(6):762-9.
  76. Jacobsen S, Jensen JC, Frei S, Jensen AL, Thoefner MB. Use of serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses: a field study.. Equine Vet J 2005 Nov;37(6):552-6.
    doi: 10.2746/042516405775314853pubmed: 16295934google scholar: lookup
  77. Daniel AJ, Leise BS, Burgess BA, Morley PS, Cloninger M, Hassel DM. Concentrations of serum amyloid A and plasma fibrinogen in horses undergoing emergency abdominal surgery.. J Vet Emerg Crit Care (San Antonio) 2016 May;26(3):344-51.
    doi: 10.1111/vec.12365pubmed: 26274017google scholar: lookup
  78. Witkowska-Piłaszewicz OD, Żmigrodzka M, Winnicka A, Miśkiewicz A, Strzelec K, Cywińska A. Serum amyloid A in equine health and disease.. Equine Vet J 2019 May;51(3):293-298.
    doi: 10.1111/evj.13062pmc: PMC7163734pubmed: 30565319google scholar: lookup
  79. Sinovich M, Villarino NF, Singer E, Robinson CS, Rubio-Martínez LM. Can blood serum amyloid A concentrations in horses differentiate synovial sepsis from extrasynovial inflammation and determine response to treatment?. Vet Rec 2020 Sep 19;187(6):235.
    doi: 10.1136/vr.105153pmc: PMC7591800pubmed: 32098906google scholar: lookup
  80. Hultén C, Demmers S. Serum amyloid A (SAA) as an aid in the management of infectious disease in the foal: comparison with total leucocyte count, neutrophil count and fibrinogen.. Equine Vet J 2002 Nov;34(7):693-8.
    doi: 10.2746/042516402776250360pubmed: 12455840google scholar: lookup
  81. McFadyen JD, Zeller J, Potempa LA, Pietersz GA, Eisenhardt SU, Peter K. C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond.. Subcell Biochem 2020;94:499-520.
    doi: 10.1007/978-3-030-41769-7_20pubmed: 32189313google scholar: lookup
  82. Jain S, Gautam V, Naseem S. Acute-phase proteins: As diagnostic tool.. J Pharm Bioallied Sci 2011 Jan;3(1):118-27.
    doi: 10.4103/0975-7406.76489pmc: PMC3053509pubmed: 21430962google scholar: lookup
  83. Ceron JJ, Eckersall PD, Martýnez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives.. Vet Clin Pathol 2005 Jun;34(2):85-99.
  84. Henriquez-Camacho C, Losa J. Biomarkers for sepsis.. Biomed Res Int 2014;2014:547818.
    doi: 10.1155/2014/547818pmc: PMC3985161pubmed: 24800240google scholar: lookup
  85. López-Martínez MJ, Franco-Martínez L, Martínez-Subiela S, Cerón JJ. Biomarkers of sepsis in pigs, horses and cattle: from acute phase proteins to procalcitonin.. Anim Health Res Rev 2022 Jun;23(1):82-99.
    doi: 10.1017/S1466252322000019pubmed: 35795920google scholar: lookup
  86. Takiguchi M, Fujinaga T, Naiki M, Mizuno S, Otomo K. Isolation, characterization, and quantitative analysis of C-reactive protein from horses.. Am J Vet Res 1990 Aug;51(8):1215-20.
    pubmed: 2117410
  87. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.. Br J Pharmacol 2010 Jan 1;159(2):253-64.
  88. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection.. Lancet 1993 Feb 27;341(8844):515-8.
    doi: 10.1016/0140-6736(93)90277-Npmc: PMC7141580pubmed: 8094770google scholar: lookup
  89. Afsar I, Sener AG. Is Procalcitonin a Diagnostic and/or Prognostic Marker in Sepsis?. Infect. Dis. Clin. Pract. 2015;23:3–6.
  90. Rieger M, Kochleus C, Teschner D, Rascher D, Barton AK, Geerlof A, Kremmer E, Schmid M, Hartmann A, Gehlen H. A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses.. Anal Bioanal Chem 2014 Sep;406(22):5507-12.
    doi: 10.1007/s00216-014-7944-zpubmed: 24928115google scholar: lookup
  91. Bonelli F, Meucci V, Divers TJ, Jose-Cunilleras E, Corazza M, Tognetti R, Guidi G, Intorre L, Sgorbini M. Plasma Procalcitonin Concentration in Healthy Horses and Horses Affected by Systemic Inflammatory Response Syndrome.. J Vet Intern Med 2015 Nov-Dec;29(6):1689-91.
    doi: 10.1111/jvim.13640pmc: PMC4895682pubmed: 26474412google scholar: lookup
  92. Teschner D, Rieger M, Koopmann C, Gehlen H. Procalcitonin in horses with an acute colic. Pferdeheilkunde 2015;31:371–377.
    doi: 10.21836/PEM20150407google scholar: lookup
  93. Kilcoyne I, Nieto JE, Dechant JE. Diagnostic value of plasma and peritoneal fluid procalcitonin concentrations in horses with strangulating intestinal lesions.. J Am Vet Med Assoc 2020 Apr 15;256(8):927-933.
    doi: 10.2460/javma.256.8.927pubmed: 32223710google scholar: lookup
  94. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.. Intensive Care Med 2017 Mar;43(3):304-377.
    doi: 10.1007/s00134-017-4683-6pubmed: 28101605google scholar: lookup
  95. Nocera I, Bonelli F, Vitale V, Meucci V, Conte G, Jose-Cunilleras E, Gracia-Calvo LA, Sgorbini M. Evaluation of Plasmatic Procalcitonin in Healthy, and in Systemic Inflammatory Response Syndrome (SIRS) Negative or Positive Colic Horses.. Animals (Basel) 2021 Jul 6;11(7).
    doi: 10.3390/ani11072015pmc: PMC8300415pubmed: 34359143google scholar: lookup
  96. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.. J Clin Invest 1985 Oct;76(4):1539-53.
    doi: 10.1172/JCI112135pmc: PMC424125pubmed: 4056039google scholar: lookup
  97. Tjalsma H, Bolhuis A, Jongbloed JD, Bron S, van Dijl JM. Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome.. Microbiol Mol Biol Rev 2000 Sep;64(3):515-47.
  98. Chenau J, Michelland S, Seve M. [Secretome: definitions and biomedical interest].. Rev Med Interne 2008 Jul;29(7):606-8.
    doi: 10.1016/j.revmed.2007.12.011pubmed: 18255200google scholar: lookup
  99. Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.. Int J Mol Sci 2017 Aug 25;18(9).
    doi: 10.3390/ijms18091852pmc: PMC5618501pubmed: 28841158google scholar: lookup
  100. van Hees HW, Schellekens WJ, Linkels M, Leenders F, Zoll J, Donders R, Dekhuijzen PN, van der Hoeven JG, Heunks LM. Plasma from septic shock patients induces loss of muscle protein.. Crit Care 2011;15(5):R233.
    doi: 10.1186/cc10475pmc: PMC3334781pubmed: 21958504google scholar: lookup
  101. Blangy-Letheule A, Persello A, Michelland S, Cunin V, Souab F, Aillerie V, Dhot J, Erraud A, Montnach J, Seve M, Bourgoin-Voillard S, Rozec B, De Waard M, Lauzier B. The Secretome Deregulations in a Rat Model of Endotoxemic Shock.. Oxid Med Cell Longev 2021;2021:6650464.
    doi: 10.1155/2021/6650464pmc: PMC8328724pubmed: 34349874google scholar: lookup
  102. Póvoa P, Salluh JI. Use of biomarkers in sepsis: many questions, few answers.. Rev Bras Ter Intensiva 2013 Mar;25(1):1-2.
  103. Wilkins PA. What's in a word? The need for SIRS and sepsis definitions in equine medicine and surgery.. Equine Vet J 2018 Jan;50(1):7-9.
    doi: 10.1111/evj.12780pubmed: 29193295google scholar: lookup

Citations

This article has been cited 0 times.